Skip to main content
Erschienen in: BMC Ophthalmology 1/2023

Open Access 01.12.2023 | Research

Orthokeratology in controlling myopia of children: a meta-analysis of randomized controlled trials

verfasst von: Xue Li, Meiling Xu, Shanshan San, Lanzheng Bian, Hui Li

Erschienen in: BMC Ophthalmology | Ausgabe 1/2023

Abstract

Background

Delaying the development and lowering the progression of myopia in children is the focus of current ophthalmology researches. We aimed to evaluate the role of orthokeratology in controlling myopia of children, to provide insights to the clinical treatment and care of children with myopia.

Methods

Two investigators searched the The Cochrane Library, Embase, Pubmed, China national knowledge infrastructure, China biomedical literature database, WanFang and Weipu databases for randomized controlled trials(RCTs) on the role of orthokeratology in controlling myopia of children up to November 5, 2022. Two researchers independently searched, screened and extracted the studies according to the inclusion and exclusion standards. RevMan5.3 software was used for statistical analysis.

Results

A total of 14 RCTs involving 2058 children were included in this meta-analysis. Synthesized outcomes indicated that orthokeratology improved the uncorrected visual acuity(MD = 0.40, 95%CI: 0.05 ~ 0.74), reduced the diopter change(MD=-3.19, 95%CI: -4.42~-1.95), changes of corneal curvature(MD=-3.21, 95%CI: -3.64~-2.79), the length of ocular axis (MD=-0.66, 95%CI: -1.27~-0.06) and amount of ocular axis change(MD=-0.42, 95%CI: -0.64~-0.21) after 1 year of wearing orthokeratology(all P < 0.05). Besides, orthokeratology reduced the diopter change (MD=-3.22, 95%CI: -4.86~-1.58), the length of ocular axis (MD=-1.15, 95%CI: -2.25~-0.06) and the amount of ocular axis change after 2 year of wearing orthokeratology (MD=-0.53, 95%CI: -0.96~-0.11) after 2 year of wearing orthokeratology (all P < 0.05). No publication biases were found amongst the synthesized outcomes (all P > 0.05).

Conclusions

Orthokeratology delays the progression of myopia in children, the long-term effects of orthokeratology need further investigations in future studies.
Hinweise
Xue Li, Meiling Xu, Shanshan San contributed equally to this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

Myopia is the refractive state in which the light of distant objects is focused in front of the retina when the eye is relaxed. It has become a global public health problem [1]. Myopia is affected by many factors, such as heredity and environment [2]. At present, it can only be controlled clinically. The commonly used methods to correct and prevent myopia include outdoor activities, drugs, wearing frame glasses, hard contact lenses and surgical treatment. In recent years, the control effect of orthokeratology on the development of myopia has been widely recognized. With the increasing number of users, the unique design of orthokeratology lenses and the way of night wear have gradually exposed clinical problems [35]. Due to the differences in research quality, there is still a lack of evaluation on myopia control effect of orthokeratology with different treatment duration.
It’s been reported that myopia in children is related to severe myopia in adulthood [6, 7]. It is important to control the development of myopia in school age children to reduce the incidence rate of severe myopia in the future [810]. There are many studies on the effectiveness of orthokeratology in controlling myopia, but there are differences in follow-up time, research design, research object, etc. This study aimed at these differences, and planned to systematically evaluate the researches on orthokeratology in controlling the development of myopia in school-age children, so as to evaluate the effectiveness of using orthokeratology in the myopia of children, and provide reliable evidences for the clinical treatment and nursing care of myopia in children.

Methods

This meta-analysis and systematic review was conducted following the preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement [11].
The databases searched in this meta-analysis included: The Cochrane Library, Embase, Pubmed, China national knowledge infrastructure, China biomedical literature database, WanFang and Weipu databases. The retrieval time limit was from the establishment of the database to November 5, 2022. Both the subject words and free words were used for literature search, the retrieval strategy was adjusted according to the specific database. The search strategies were as follows: (“orthokeratology” OR “orthokerological procedure” OR “procedure” OR “orthokerological” OR “procedures” OR “orthokerological” OR “orthokerological lens” OR “ortho-K lens” OR “OK lens” OR “reverse geometry lens”) AND (“Myopia” OR “nearsightedness” OR “Near sight” OR “short sight” OR “shortsightedness”). Besides, in order to include more related studies for this meta-analysis, the literatures of relevant reviews and references were searched manually.

Inclusion and exclusion criteria

The inclusion criteria of this meta-analysis were as follows: Children with myopia whose age was 6–18 years old and whose spherical lens was less than − 6.00 D and cylindrical lens was less than − 1.5D, the follow-up period should be at least one year; the children underwent orthokeratology or frame mirror treatment; related outcomes were reported including axial length, corneal curvature, naked eye vision and diopter et al. the study design should be randomized controlled trial (RCT).
The exclusion criteria of this meta-analysis were as follows: reports including reviews, letters, case reports and comments were excluded; repeated published literature; the full text of literature could not be obtained.

Literature screening and data extraction

Two researchers independently searched, screened, extracted and checked the documents according to the inclusion and exclusion standards. We removed the irrelevant documents by reading the title and abstract, and further read the full text of the retained documents to determine whether they were included. If there was any disagreement between the two researchers, a third researched was invited for discussion to obtain a consistent result.
The two authors extracted data from the original literature, including the author’s name, publication time, age, follow-up time, number of eyes, outcome indicators and research conclusions. All differences and disputes are resolved through discussion for reaching consensus.

Quality assessment

The risk of bias of included RCTs as evaluated using the Cochrane risk of bias assessment instrument [12] by two authors. The bias has been evaluated across four domains: random sequence generation; allocation concealment; blind method; incomplete outcome data and selective reporting. Every domain could be rated as “unclear” OR “low” OR “high” risk of bias accordingly.

Statistical analysis

RevMan5.3 software was used for statistical analysis in this meta-analysis. Continuous results were analyzed by mean difference (MD), and binary variables were evaluated by relative risk (RR). P values and 95% confidence intervals (95% CI) were also obtained. The heterogeneity between studies was tested with I2 statistic. When I2 < 50% or P > 0.1, the heterogeneity was considered acceptable, and the MD was combined according to the fixed effect model; On the contrary, if significant heterogeneity (I2 > 50% or P < 0.1) were considered, a random effect model was used to combine the data. Besides, we examined the robustness of meta-analysis using sensitivity analysis. P<0.05 was considered that the differences were statistically significant in this study.

Results

RCT selection

The process of RCT selection is presented in Fig. 1. Initially, 194 reports were identified. After removing 12 duplicates, 182 studies remained. By reviewing the title and abstract, 137 unmatched reports were further excluded. Among the remaining 45 reports, 31 studies were removed after reading the full text. Finally, 14 RCTs [1326] were included in this meta-analysis.

The characteristics of included RCTs

The 14 included RCTs were published between 2012 and 2020. A total of 2058 children were included in this meta-analysis, including 995 children in the orthokeratology group and 1063 children in the control group. All the included RCTs reported that there were no significant differences in the age, gender et al. characteristics. The characteristics of the included RCTs are presented in Table 1.
Table 1
The characteristics of included RCTs
RCT
Country
Sample size
Number of eyes
Age(years)
Criteria
Type of orthokeratology
Wearing method
Duration of follow-up(year)
  
Orthokeratology group
Control group
Orthokeratology group
Control group
     
Bian 2020
China
100
100
100
100
8 ~ 14
Diopter: -0.75~-5.00D; Cis return astigmatism < 1.50D
IV-DF Dream David
Night wear
1
Charm 2013
China
12
16
24
32
8 ~ 16
SEQ refraction at least − 5.75 diopters (D) and myopia − 5.00 D
NA
NA
1
Cho 2012
South Korea
37
41
74
82
6 ~ 10
Myopia degree: 0.50 ~ 4.00D; Astigmatism < 1.50D
NA
NA
2
 
Dong 2013
China
123
123
236
246
8 ~ 15
Sphere scope: -0.75~-6.00 DS; Range of column mirror − 0.50~-1.50DC
Dream David
Night wear
2
 
Jiang 2014
China
50
45
90
90
8 ~ 15
Spherical degree 0~-6.00 ODS; Cis return astigmatism 0~-1.50 DC
Hengtai
NA
3
 
Jiang 2018
China
43
40
86
80
8 ~ 14
SEQ lens diopter: -0.15 ~ − 5.00 D; Range of cis return astigmatism < 150 D
Hengtai
Night wear
2
 
Li 2016
China
48
48
96
96
8 ~ 18
Diopter: -0.15D~-6.00D; Conforming astigmatism < 1.50 D
NA
NA
1
 
Li 2020
China
75
75
150
150
12 ~ 18
Diopter: -2.00~-4.30 DS, − 0.50~-1.00 DC
Dream David
Night wear
1
 
Liu 2018
USA
60
60
60
60
7 ~ 12
Diopter: − 3.50~-6.00 D; Astigmatism<-1.50D
Jingshi Optics
Night wear
1
 
Lv 2019
China
60
62
60
62
6–15
Diopter: − 2.00~-5.0D; Astigmatism<-2.50D
Dream David
Night wear
1
 
Tang 2020
China
60
60
98
93
8 ~ 16
SEQ: − 1.50~- 6.00 D; Degree of column mirror < 1.0 0 D
NA
Night wear
1
 
Zhang 2017
China
80
80
160
160
12 ~ 18
Diopter: 1.00 ~ 5.00; Column mirror range ≤ -1.50 D
NA
Night wear
2
 
Zhou 2016
China
167
233
334
466
9 ~ 15
Astigmatism<-1.50 DC; SEQ: -2.75 ~ 5.60 DS
Euclid
NA
2
 
Zhu 2014
China
80
80
160
160
12 ~ 18
Diopter: -1.00~-4.00 DS, < 1.00 DC
NA
NA
1
 
SEQ, spherical equivalent; NA, not available

RCT quality

The quality of included RCTs are showed in Figs. 2 and 3. Some studies that did not explicitly report blinding methods for intervention, outcome measurement personnel, performance bias, and detection bias were rated as ‘‘unclear”. Other evaluation items were rated as ‘‘low risk”. Generally, the included RCTs had moderate risk of bias.

Meta-analysis

The uncorrected visual acuity after 1 year of wearing orthokeratology Five RCTs reported the uncorrected visual acuity after 1 year of wearing orthokeratology, the result had significant heterogeneity (I2 = 100%, P < 0.001), then random effect model was applied for data analysis. The synthesized result indicated that the uncorrected visual acuity after 1 year of wearing orthokeratology was significantly higher than that of control group (MD = 0.40, 95%CI: 0.05 ~ 0.74, P = 0.02, Fig. 4a).
The diopter change after 1 year of wearing orthokeratology Seven RCTs reported the diopter change after 1 year of wearing orthokeratology, the result had significant heterogeneity (I2 = 100%, P < 0.001), then random effect model was applied for data analysis. The synthesized result indicated that the diopter change after 1 year of wearing orthokeratology was significantly less than that of control group (MD=-3.19, 95%CI: -4.42~-1.95, P < 0.001, Fig. 4b).
The diopter change after 2 years of wearing orthokeratology Four RCTs reported the diopter change after 2 year of wearing orthokeratology, the result had significant heterogeneity (I2 = 100%, P < 0.001), then random effect model was applied for data analysis. The synthesized result indicated that the diopter change after 2 year of wearing orthokeratology was significantly less than that of control group (MD=-3.22, 95%CI: -4.86~-1.58, P < 0.001, Fig. 4c).
The changes of corneal curvature after 1 year of wearing orthokeratology Four RCTs reported the changes of corneal curvature after 1 year of wearing orthokeratology, the result had significant heterogeneity (I2 = 92%, P < 0.001), then random effect model was applied for data analysis. The synthesized result indicated that the changes of corneal curvature after 1 year of wearing orthokeratology was significantly less than that of control group (MD=-3.21, 95%CI: -3.64~-2.79, P < 0.001, Fig. 4d).
The length of ocular axis after 1 year of wearing orthokeratology Eight RCTs reported the length of ocular axis after 1 year of wearing orthokeratology, the result had significant heterogeneity (I2 = 99%, P < 0.001), then random effect model was applied for data analysis. The synthesized result indicated that the length of ocular axis after 1 year of wearing orthokeratology was significantly less than that of control group (MD=-0.66, 95%CI: -1.27~-0.06, P < 0.001, Fig. 5a).
The length of ocular axis after 2 year of wearing orthokeratology Four RCTs reported the length of ocular axis after 2 year of wearing orthokeratology, the result had significant heterogeneity (I2 = 100%, P < 0.001), then random effect model was applied for data analysis. The synthesized result indicated that the length of ocular axis after 2 year of wearing orthokeratology was significantly less than that of control group (MD=-1.15, 95%CI: -2.25~-0.06, P < 0.001, Fig. 5b).
The amount of ocular axis change after 1 year of wearing orthokeratology Four RCTs reported the amount of ocular axis change after 1 year of wearing orthokeratology, the result had significant heterogeneity (I2 = 99%, P < 0.001), then random effect model was applied for data analysis. The synthesized result indicated that the amount of ocular axis change after 1 year of wearing orthokeratology was significantly less than that of control group (MD=-0.42, 95%CI: -0.64~-0.21, P < 0.001, Fig. 5c).
the amount of ocular axis change after 2 year of wearing orthokeratology Three RCTs reported the the amount of ocular axis change after 2 year of wearing orthokeratology, the result had significant heterogeneity (I2 = 99%, P < 0.001), then random effect model was applied for data analysis. The synthesized result indicated that the amount of ocular axis change after 2 year of wearing orthokeratology was significantly less than that of control group (MD=-0.53, 95%CI: -0.96~-0.11, P < 0.001, Fig. 5d).

Publication bias

The funnel plots are presented in Figs. 6 and 7. The dots were evenly distributed in the funnel plots, and the Egger test results indicated that there were no publication biases in the synthesized outcomes (all P > 0.05).
We examined the robustness of meta-analysis using sensitivity analysis by excluding the RCTs one by one, the synthesized results did not statistically change, indicating that the synthesized outcomes were robust.

Discussions

Myopia is a global health and social problem. The occurrence and development of the disease mainly occurs in children and adolescents. Therefore, the control of myopia has focused on children and adolescents. Myopia, especially high myopia, usually leads to serious consequences, including glaucoma, macular degeneration, retinal detachment and cataract, which may lead to irreversible visual impairment in later life [2729].At the same time, high myopia is related to the reduction of vision related quality of life, and has a significant socio-economic impact [30, 31]. Compared with previous meta-analyses [32, 33], this study has included more sample size and analyzed outcomes. The results of this meta-analysis have showed that compared with the frame lens, the naked vision, corneal curvature, diopter, axial length and their changes of the patients with the corneal plastic lens are statistically different, and the myopia control effect are better than the frame lens. Orthokeratology is a beneficial to control the myopia progression of children, which is a good option for myopia control and care.
At present, the measures to control the progress of children’s myopia include pharmacology, environment, surgery and optics [3436]. The drug control of myopia mainly uses atropine. 0.01% atropine can reduce refractive error by about 45%. Compared with the control group, the axial control effect is not obvious, but the side effects and reactions after drug withdrawal are less, 1% atropine may reduce myopia progression by 60%~80% [37]. The extension of outdoor activities and the reduction of children’s schoolwork burden are more effective in the primary prevention of myopia [38]. Wearing frame glasses is a common means to control myopia. However, because of the distance between the lens and the apex of the cornea, the image magnification is bound to change. The lens itself also limits the field of vision, and this phenomenon is more obvious in myopic eyes with higher degrees [39]. Compared with frame glasses, Orthokeratology has unique advantages. The distance between the lens and the eye is reduced, it can minimize the magnification reduction of the retinal image caused by high refraction [38, 40]. However, it must be noted that there is a lack of corneal topography analysis after orthokeratology to define the optical effect of the molding on peripheral defocus from each study. Contrary to soft multifocal or glasses, the visual impact on peripheral defocus of orthokeratology can vary with the brand and the fitter philosophy.
Myopia is the result of genetic and environmental factors, and its pathogenesis and progression mechanism are still unclear. At present, the mainstream mechanisms include regulation mechanism, hyperopic defocusing mechanism, etc [41, 42]. The stimulating effect of periretinal hyperopia defocus on central axial myopia [43]. It has been reported that in the later stage, significant differences in axial length and peripheral retinal morphology are found between people with progressive myopia and those with stable myopia [44]. Previous research [45] shows that myopic defocusing can slow down the progress of myopia. The principle of orthokeratology to control myopia is based on defocusing theory. Compared with the traditional monocular frame glasses that may increase the peripheral hyperopia defocusing, orthokeratology changes the central shape of the cornea, promotes the migration of corneal epithelial cells, inhibits hyperopia defocusing, and provides myopia defocusing for the peripheral retina through the mechanical pressure of the flat base arc designed in inverse geometry and the negative pressure suction of the tear under the reverse arc [46, 47]. For astigmatic patients, the progression of myopia is not related to the initial astigmatism, but related to the way of myopia control [48]. Therefore, the rational use of orthokeratology can effectively control the development of myopia in children.
It’s been reported that the intraocular pressure measured by non-contact intraocular pressure after orthokeratology is lower than the actual value, and is significantly related to the thinning of central corneal thickness after wearing glasses [49]. Previous study [50] has measured intraocular pressure with dynamic contour tonometer before and after wearing, there is no significant difference. They have believed that there is no effect on actual intraocular pressure after orthokeratology. Myopia is one of the risk factors of glaucoma. For patients who use non-contact tonometer to recheck intraocular pressure, they may miss the early stage of glaucoma, so they should be alert in clinical work [51]. Previous study [52] has found that Goldmann related intraocular pressure and corneal compensated intraocular pressure decreased one week after orthokeratology, and have become stable after reaching the minimum one week. The mechanism of this decrease in intraocular pressure may be that the base arc of the lens contacts the center of the friction cornea, and the compression force of the eyelids produces a continuous massage force on the eyeball, forcing the aqueous humor to drain faster, so that the intraocular pressure decreases [53]. Therefore, orthokeratology is a safe means to prevent and control myopia, but improving the visual quality of the lens optical area, reducing corneal irritation, improving tear circulation and tear film stability are the improvement directions of orthokeratology [5456]. For myopic patients, it is very necessary to follow up regularly and strengthen lens care.
There are some limitations in this study that are worth considering. Firstly, fewer high-quality documents are included, and the possibility of bias and error is increased; Secondly, there is too large I2 amongst the results, yet we can not perform the subgroup analysis limited by the reported data. Thirdly, we only include Chinese and English literature, which may have some language bias; Finally, the number of included RCTs and the sample size were limited, and extrapolation of the meta-analysis results was limited to some extent. Future studies with rigorous design from different areas are needed to evaluate the effects of orthokeratology in myopia control.

Conclusions

In conclusion, existing evidences have showed that orthokeratology has a positive effect on slowing down the development of myopia in children. Whether there are differences in the long-term efficacy and safety of OK for children of different ethnic groups, as well as the efficacy of different OK for patients with different myopia and different ages, still needs to be further verified by a large sample of high-quality RCTs.

Acknowledgements

None.

Declarations

Competing interests

The authors declare no competing interests.
Not applicable.
In this study, all methods were performed in accordance with the relevant guidelines and regulations. Ethics approval and consent to participate are not necessary since our study is a meta-analysis.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Han X, Liu C, Chen Y, He M. Myopia prediction: a systematic review. Eye (Lond). 2022;36(5):921–9.PubMedCrossRef Han X, Liu C, Chen Y, He M. Myopia prediction: a systematic review. Eye (Lond). 2022;36(5):921–9.PubMedCrossRef
2.
Zurück zum Zitat Alvarez-Peregrina C, Martinez-Perez C, Sanchez-Tena MA. Myopia and other Visual disorders in Children. Int J Environ Res Public Health 2022, 19(15). Alvarez-Peregrina C, Martinez-Perez C, Sanchez-Tena MA. Myopia and other Visual disorders in Children. Int J Environ Res Public Health 2022, 19(15).
3.
Zurück zum Zitat Hiraoka T. Myopia control with Orthokeratology: a review. Eye Contact Lens. 2022;48(3):100–4.PubMedCrossRef Hiraoka T. Myopia control with Orthokeratology: a review. Eye Contact Lens. 2022;48(3):100–4.PubMedCrossRef
4.
Zurück zum Zitat Tricard D, Marillet S, Ingrand P, Bullimore MA, Bourne RRA, Leveziel N. Progression of myopia in children and teenagers: a nationwide longitudinal study. Br J Ophthalmol. 2022;106(8):1104–9.PubMed Tricard D, Marillet S, Ingrand P, Bullimore MA, Bourne RRA, Leveziel N. Progression of myopia in children and teenagers: a nationwide longitudinal study. Br J Ophthalmol. 2022;106(8):1104–9.PubMed
5.
Zurück zum Zitat Russo A, Boldini A, Romano D, Mazza G, Bignotti S, Morescalchi F, Semeraro F. Myopia: mechanisms and strategies to slow down its progression. J Ophthalmol. 2022;2022:1004977.PubMedPubMedCentralCrossRef Russo A, Boldini A, Romano D, Mazza G, Bignotti S, Morescalchi F, Semeraro F. Myopia: mechanisms and strategies to slow down its progression. J Ophthalmol. 2022;2022:1004977.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Lee SS, Lingham G, Sanfilippo PG, Hammond CJ, Saw SM, Guggenheim JA, Yazar S, Mackey DA. Incidence and progression of myopia in early adulthood. JAMA Ophthalmol. 2022;140(2):162–9.PubMedCrossRef Lee SS, Lingham G, Sanfilippo PG, Hammond CJ, Saw SM, Guggenheim JA, Yazar S, Mackey DA. Incidence and progression of myopia in early adulthood. JAMA Ophthalmol. 2022;140(2):162–9.PubMedCrossRef
7.
Zurück zum Zitat Wang Y, Liu Y, Zhu X, Zhou X, He JC, Qu X. Corneal and lenticular biometry in Chinese children with myopia. Clin Exp Optom 2022:1–9. Wang Y, Liu Y, Zhu X, Zhou X, He JC, Qu X. Corneal and lenticular biometry in Chinese children with myopia. Clin Exp Optom 2022:1–9.
8.
Zurück zum Zitat Wang YM, Lu SY, Zhang XJ, Chen LJ, Pang CP, Yam JC. Myopia Genetics and Heredity. Child (Basel) 2022, 9(3). Wang YM, Lu SY, Zhang XJ, Chen LJ, Pang CP, Yam JC. Myopia Genetics and Heredity. Child (Basel) 2022, 9(3).
9.
Zurück zum Zitat Matsumura S, Dannoue K, Kawakami M, Uemura K, Kameyama A, Takei A, Hori Y. Prevalence of myopia and its Associated factors among Japanese Preschool Children. Front Public Health. 2022;10:901480.PubMedPubMedCentralCrossRef Matsumura S, Dannoue K, Kawakami M, Uemura K, Kameyama A, Takei A, Hori Y. Prevalence of myopia and its Associated factors among Japanese Preschool Children. Front Public Health. 2022;10:901480.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Dragomirova M, Antonova A, Stoykova S, Mihova G, Grigorova D. Myopia in Bulgarian school children: prevalence, risk factors, and health care coverage. BMC Ophthalmol. 2022;22(1):248.PubMedPubMedCentralCrossRef Dragomirova M, Antonova A, Stoykova S, Mihova G, Grigorova D. Myopia in Bulgarian school children: prevalence, risk factors, and health care coverage. BMC Ophthalmol. 2022;22(1):248.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.PubMedPubMedCentralCrossRef Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, et al. The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.PubMedPubMedCentralCrossRef Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, et al. The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Bian S, Liu H, Lin J. A randomized controlled study on the clinical effect of myopia children’s corneal plastic lens and frame glasses for one year. Chin J Experimental Ophthalmol. 2020;38(2):121–7. Bian S, Liu H, Lin J. A randomized controlled study on the clinical effect of myopia children’s corneal plastic lens and frame glasses for one year. Chin J Experimental Ophthalmol. 2020;38(2):121–7.
14.
Zurück zum Zitat Charm J, Cho P. High myopia-partial reduction ortho-k: a 2-year randomized study. Optom Vis Sci. 2013;90(6):530–9.PubMedCrossRef Charm J, Cho P. High myopia-partial reduction ortho-k: a 2-year randomized study. Optom Vis Sci. 2013;90(6):530–9.PubMedCrossRef
15.
Zurück zum Zitat Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci. 2012;53(11):7077–85.PubMedCrossRef Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci. 2012;53(11):7077–85.PubMedCrossRef
16.
Zurück zum Zitat Dong J, Liu Z, Feng Y. A comparative study on the correction of juvenile myopia with orthokeratology and ordinary frame glasses. Chin J Strabismus Pediatr Ophthalmol. 2013;21(1):6–9. Dong J, Liu Z, Feng Y. A comparative study on the correction of juvenile myopia with orthokeratology and ordinary frame glasses. Chin J Strabismus Pediatr Ophthalmol. 2013;21(1):6–9.
17.
Zurück zum Zitat Jiang D, Li M, Cao S. Long term effect study of orthokeratology on myopia correction in adolescents. J Hubei Univ Sci Technol. 2014;28(5):407–9. Jiang D, Li M, Cao S. Long term effect study of orthokeratology on myopia correction in adolescents. J Hubei Univ Sci Technol. 2014;28(5):407–9.
18.
Zurück zum Zitat Jiang L, Zhu Y, Zhang Y. Clinical observation on the correction of low to moderate myopia with corneal plastic lens. China Grass Roots Medicine. 2018;25(17):2236–9. Jiang L, Zhu Y, Zhang Y. Clinical observation on the correction of low to moderate myopia with corneal plastic lens. China Grass Roots Medicine. 2018;25(17):2236–9.
19.
Zurück zum Zitat Li W. Clinical study on Orthokeratology Controlling the Progress of Myopia in adolescents. Health. 2020;7(2):63–5. Li W. Clinical study on Orthokeratology Controlling the Progress of Myopia in adolescents. Health. 2020;7(2):63–5.
20.
Zurück zum Zitat Li Y. Corneal plastic lenses in controlling the development of juvenile myopia. Qingdao: Qingdao University; 2016. Li Y. Corneal plastic lenses in controlling the development of juvenile myopia. Qingdao: Qingdao University; 2016.
21.
Zurück zum Zitat Liu C, Xin X. Short term clinical effect of primary school students wearing orthokeratology. J Baotou Med Coll. 2018;34(4):6–8. Liu C, Xin X. Short term clinical effect of primary school students wearing orthokeratology. J Baotou Med Coll. 2018;34(4):6–8.
22.
Zurück zum Zitat Lv T, Wang L, Zhou L, Qin J, Ma H, Shi M. Regimen study of high myopia-partial reduction Orthokeratology. Eye Contact Lens. 2020;46(3):141–6.CrossRef Lv T, Wang L, Zhou L, Qin J, Ma H, Shi M. Regimen study of high myopia-partial reduction Orthokeratology. Eye Contact Lens. 2020;46(3):141–6.CrossRef
23.
Zurück zum Zitat Tang H, Ling H, Wu X. Monitoring the role of orthokeratology in the prevention and control of juvenile myopia through ocular axis measurement. China Contemp Med. 2020;27(4):152–4. Tang H, Ling H, Wu X. Monitoring the role of orthokeratology in the prevention and control of juvenile myopia through ocular axis measurement. China Contemp Med. 2020;27(4):152–4.
24.
Zurück zum Zitat Zhang C, Wei M. Clinical observation on the treatment of juvenile mild to moderate myopia with orthokeratology. Disease Monit Control. 2017;11(2):148–9. Zhang C, Wei M. Clinical observation on the treatment of juvenile mild to moderate myopia with orthokeratology. Disease Monit Control. 2017;11(2):148–9.
25.
Zurück zum Zitat Zhou Z, Xu S, Yi S. Curative effect of orthokeratology on juvenile myopia astigmatism and its influence on corneal endothelial cells. Int J Ophthalmol. 2016;16(8):1525–7. Zhou Z, Xu S, Yi S. Curative effect of orthokeratology on juvenile myopia astigmatism and its influence on corneal endothelial cells. Int J Ophthalmol. 2016;16(8):1525–7.
26.
Zurück zum Zitat Zhu F. Clinical study on the control of juvenile myopia progress by orthokeratology. Zunyi: Zunyi Medical College; 2014. Zhu F. Clinical study on the control of juvenile myopia progress by orthokeratology. Zunyi: Zunyi Medical College; 2014.
27.
Zurück zum Zitat Rathi M, Chhabra S, Sachdeva S, Rustagi IM, Soni D, Dhania S. Correlation of parental and childhood myopia in children aged 5–16 years in North India. Indian J Ophthalmol. 2022;70(9):3366–8.PubMedPubMedCentralCrossRef Rathi M, Chhabra S, Sachdeva S, Rustagi IM, Soni D, Dhania S. Correlation of parental and childhood myopia in children aged 5–16 years in North India. Indian J Ophthalmol. 2022;70(9):3366–8.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Ovenseri-Ogbomo G, Osuagwu UL, Ekpenyong BN, Agho K, Ekure E, Ndep AO, Ocansey S, Mashige KP, Naidoo KS, Ogbuehi KC. Systematic review and meta-analysis of myopia prevalence in African school children. PLoS ONE. 2022;17(2):e0263335.PubMedPubMedCentralCrossRef Ovenseri-Ogbomo G, Osuagwu UL, Ekpenyong BN, Agho K, Ekure E, Ndep AO, Ocansey S, Mashige KP, Naidoo KS, Ogbuehi KC. Systematic review and meta-analysis of myopia prevalence in African school children. PLoS ONE. 2022;17(2):e0263335.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Lipson MJ, Boland B, McAlinden C. Vision-related quality of life with myopia management: a review. Cont Lens Anterior Eye. 2022;45(3):101538.PubMedCrossRef Lipson MJ, Boland B, McAlinden C. Vision-related quality of life with myopia management: a review. Cont Lens Anterior Eye. 2022;45(3):101538.PubMedCrossRef
30.
Zurück zum Zitat Zhang J, Li Z, Ren J, Wang W, Dai J, Li C, Huang X, Sun X, Liu L, Wang C. Prevalence of myopia: a large-scale population-based study among children and adolescents in weifang, China. Front Public Health. 2022;10:924566.PubMedPubMedCentralCrossRef Zhang J, Li Z, Ren J, Wang W, Dai J, Li C, Huang X, Sun X, Liu L, Wang C. Prevalence of myopia: a large-scale population-based study among children and adolescents in weifang, China. Front Public Health. 2022;10:924566.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Zhang H, Lam CSY, Tang WC, Leung M, Qi H, Lee PH, To CH. Myopia control effect is influenced by baseline relative peripheral refraction in children wearing Defocus Incorporated multiple segments (DIMS) spectacle lenses. J Clin Med 2022, 11(9). Zhang H, Lam CSY, Tang WC, Leung M, Qi H, Lee PH, To CH. Myopia control effect is influenced by baseline relative peripheral refraction in children wearing Defocus Incorporated multiple segments (DIMS) spectacle lenses. J Clin Med 2022, 11(9).
32.
Zurück zum Zitat Guan M, Zhao W, Geng Y, Zhang Y, Ma J, Chen Z, Peng M, Li Y. Changes in axial length after orthokeratology lens treatment for myopia: a meta-analysis. Int Ophthalmol. 2020;40(1):255–65.PubMedCrossRef Guan M, Zhao W, Geng Y, Zhang Y, Ma J, Chen Z, Peng M, Li Y. Changes in axial length after orthokeratology lens treatment for myopia: a meta-analysis. Int Ophthalmol. 2020;40(1):255–65.PubMedCrossRef
33.
Zurück zum Zitat Tsai HR, Wang JH, Huang HK, Chen TL, Chen PW, Chiu CJ. Efficacy of atropine, orthokeratology, and combined atropine with orthokeratology for childhood myopia: a systematic review and network meta-analysis. J Formos Med Assoc. 2022;121(12):2490–500.PubMedCrossRef Tsai HR, Wang JH, Huang HK, Chen TL, Chen PW, Chiu CJ. Efficacy of atropine, orthokeratology, and combined atropine with orthokeratology for childhood myopia: a systematic review and network meta-analysis. J Formos Med Assoc. 2022;121(12):2490–500.PubMedCrossRef
34.
Zurück zum Zitat Liu YL, Jhang JP, Hsiao CK, Tsai TH, Wang IJ. Influence of parental behavior on myopigenic behaviors and risk of myopia: analysis of nationwide survey data in children aged 3 to 18 years. BMC Public Health. 2022;22(1):1637.PubMedPubMedCentralCrossRef Liu YL, Jhang JP, Hsiao CK, Tsai TH, Wang IJ. Influence of parental behavior on myopigenic behaviors and risk of myopia: analysis of nationwide survey data in children aged 3 to 18 years. BMC Public Health. 2022;22(1):1637.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Wang W, Xiang Y, Zhu L, Zheng S, Ji Y, Lv B, Xiong L, Li Z, Yi S, Huang H, et al. Myopia progression and associated factors of refractive status in children and adolescents in Tibet and Chongqing during the COVID-19 pandemic. Front Public Health. 2022;10:993728.PubMedPubMedCentralCrossRef Wang W, Xiang Y, Zhu L, Zheng S, Ji Y, Lv B, Xiong L, Li Z, Yi S, Huang H, et al. Myopia progression and associated factors of refractive status in children and adolescents in Tibet and Chongqing during the COVID-19 pandemic. Front Public Health. 2022;10:993728.PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Gopalakrishnan A, Hussaindeen JR, Sivaraman V, Swaminathan M, Wong YL, Armitage JA, Gentle A, Backhouse S. Prevalence of myopia among urban and suburban school children in Tamil Nadu, South India: findings from the Sankara Nethralaya Tamil Nadu Essilor Myopia (STEM) study. Ophthalmic Physiol Opt. 2022;42(2):345–57.PubMedPubMedCentralCrossRef Gopalakrishnan A, Hussaindeen JR, Sivaraman V, Swaminathan M, Wong YL, Armitage JA, Gentle A, Backhouse S. Prevalence of myopia among urban and suburban school children in Tamil Nadu, South India: findings from the Sankara Nethralaya Tamil Nadu Essilor Myopia (STEM) study. Ophthalmic Physiol Opt. 2022;42(2):345–57.PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Zhu L, Ding L, Wang J. Meta analysis of the effectiveness and safety of corneal plastic lens in controlling myopia in primary and secondary school students. Chin School Doctor. 2022;18(4):36–9. Zhu L, Ding L, Wang J. Meta analysis of the effectiveness and safety of corneal plastic lens in controlling myopia in primary and secondary school students. Chin School Doctor. 2022;18(4):36–9.
38.
Zurück zum Zitat Zhang KY, Lyu HB, Yang JR, Qiu WQ. Efficacy of long-term orthokeratology treatment in children with anisometropic myopia. Int J Ophthalmol. 2022;15(1):113–8.PubMedPubMedCentralCrossRef Zhang KY, Lyu HB, Yang JR, Qiu WQ. Efficacy of long-term orthokeratology treatment in children with anisometropic myopia. Int J Ophthalmol. 2022;15(1):113–8.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Cho P, Cheung SW. Protective role of Orthokeratology in reducing risk of Rapid Axial Elongation: a reanalysis of Data from the ROMIO and TO-SEE studies. Invest Ophthalmol Vis Sci. 2017;58(3):1411–6.PubMedCrossRef Cho P, Cheung SW. Protective role of Orthokeratology in reducing risk of Rapid Axial Elongation: a reanalysis of Data from the ROMIO and TO-SEE studies. Invest Ophthalmol Vis Sci. 2017;58(3):1411–6.PubMedCrossRef
40.
Zurück zum Zitat Lipson MJ. The role of Orthokeratology in Myopia Management. Eye Contact Lens. 2022;48(5):189–93.PubMedCrossRef Lipson MJ. The role of Orthokeratology in Myopia Management. Eye Contact Lens. 2022;48(5):189–93.PubMedCrossRef
41.
Zurück zum Zitat Tao Z, Wang J, Zhu M, Lin Z, Zhao J, Tang Y, Deng H. Does Orthokeratology wearing affect the tear quality of children? Front Pediatr. 2021;9:773484.PubMedCrossRef Tao Z, Wang J, Zhu M, Lin Z, Zhao J, Tang Y, Deng H. Does Orthokeratology wearing affect the tear quality of children? Front Pediatr. 2021;9:773484.PubMedCrossRef
42.
Zurück zum Zitat Chen X, Xiong Y, Liu F, Wang J, Yang B, Liu L. Factors determining the myopia control effect of an orthokeratology lens: a two-year multi-level model. Ophthalmic Physiol Opt. 2022;42(4):786–96.PubMedCrossRef Chen X, Xiong Y, Liu F, Wang J, Yang B, Liu L. Factors determining the myopia control effect of an orthokeratology lens: a two-year multi-level model. Ophthalmic Physiol Opt. 2022;42(4):786–96.PubMedCrossRef
43.
Zurück zum Zitat Shinojima A, Negishi K, Tsubota K, Kurihara T. Multiple factors causing myopia and the possible treatments: a Mini Review. Front Public Health. 2022;10:897600.PubMedPubMedCentralCrossRef Shinojima A, Negishi K, Tsubota K, Kurihara T. Multiple factors causing myopia and the possible treatments: a Mini Review. Front Public Health. 2022;10:897600.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Jiang M, Zhou Q, Chen J, Liu X, Wang L. Meta analysis of the influence of corneal plastic lens on the ocular axis of juvenile myopia. Chin J Practical Ophthalmol. 2014;32(11):1252–6. Jiang M, Zhou Q, Chen J, Liu X, Wang L. Meta analysis of the influence of corneal plastic lens on the ocular axis of juvenile myopia. Chin J Practical Ophthalmol. 2014;32(11):1252–6.
45.
Zurück zum Zitat Guan D, Xu J. Analysis of the efficacy and safety of corneal plastic lens in controlling juvenile myopia. Gansu Med. 2018;37(2):2–5. Guan D, Xu J. Analysis of the efficacy and safety of corneal plastic lens in controlling juvenile myopia. Gansu Med. 2018;37(2):2–5.
46.
Zurück zum Zitat Duan C, Feng F, Liu L, Qu F, Yang Z, Zhang H, Jiang C. Group-based trajectory modeling to identify factors influencing the development of myopia in patients receiving Orthokeratology. Int J Gen Med. 2022;15:4151–62.PubMedPubMedCentralCrossRef Duan C, Feng F, Liu L, Qu F, Yang Z, Zhang H, Jiang C. Group-based trajectory modeling to identify factors influencing the development of myopia in patients receiving Orthokeratology. Int J Gen Med. 2022;15:4151–62.PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Sun L, Li ZX, Chen Y, He ZQ, Song HX. The effect of orthokeratology treatment zone decentration on myopia progression. BMC Ophthalmol. 2022;22(1):76.PubMedPubMedCentralCrossRef Sun L, Li ZX, Chen Y, He ZQ, Song HX. The effect of orthokeratology treatment zone decentration on myopia progression. BMC Ophthalmol. 2022;22(1):76.PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Tang WT, Li SB, Li YJ, Tang ZP, Ma D. [Clinical observation of orthokeratology with increased compression factor in the treatment of myopia]. Zhonghua Yan Ke Za Zhi. 2022;58(11):907–13.PubMed Tang WT, Li SB, Li YJ, Tang ZP, Ma D. [Clinical observation of orthokeratology with increased compression factor in the treatment of myopia]. Zhonghua Yan Ke Za Zhi. 2022;58(11):907–13.PubMed
49.
Zurück zum Zitat Huo S, Liu B, Zhou S. Research progress on the safety and effectiveness of keratoplasty for myopia. J Local Surg. 2019;28(4):4–6. Huo S, Liu B, Zhou S. Research progress on the safety and effectiveness of keratoplasty for myopia. J Local Surg. 2019;28(4):4–6.
50.
Zurück zum Zitat Dapeng T. Current status of research on the efficacy and safety of corneal plastic lens in the treatment of myopia. Practical Clin Med. 2018;19(1):104–7. Dapeng T. Current status of research on the efficacy and safety of corneal plastic lens in the treatment of myopia. Practical Clin Med. 2018;19(1):104–7.
51.
Zurück zum Zitat Rui W, Jingru S, Xiangxia L. Research progress in the correction of myopia with corneal plastic lens. J Eye Ear Nose Throat Traditional Chin Med. 2019;9(4):3–6. Rui W, Jingru S, Xiangxia L. Research progress in the correction of myopia with corneal plastic lens. J Eye Ear Nose Throat Traditional Chin Med. 2019;9(4):3–6.
52.
Zurück zum Zitat Jun J, Xiaomei Q, Xiao Y. Effectiveness and safety of aspherical keratoplasty lens in correcting myopia. Chin J Optometry Visual Sci. 2020;22(8):7–9. Jun J, Xiaomei Q, Xiao Y. Effectiveness and safety of aspherical keratoplasty lens in correcting myopia. Chin J Optometry Visual Sci. 2020;22(8):7–9.
53.
Zurück zum Zitat Meijuan Y, Quan L. Research progress in the control of myopia anisometropia with corneal plastic lens. Int J Ophthalmol. 2022;22(8):5–9. Meijuan Y, Quan L. Research progress in the control of myopia anisometropia with corneal plastic lens. Int J Ophthalmol. 2022;22(8):5–9.
54.
Zurück zum Zitat Kuo YK, Chen YT, Chen HM, Wu PC, Sun CC, Yeung L, Lin KK, Chen HC, Chuang LH, Lai CC et al. Efficacy of myopia control and distribution of corneal epithelial thickness in children treated with Orthokeratology assessed using Optical Coherence Tomography. J Pers Med 2022, 12(2). Kuo YK, Chen YT, Chen HM, Wu PC, Sun CC, Yeung L, Lin KK, Chen HC, Chuang LH, Lai CC et al. Efficacy of myopia control and distribution of corneal epithelial thickness in children treated with Orthokeratology assessed using Optical Coherence Tomography. J Pers Med 2022, 12(2).
55.
Zurück zum Zitat Ding C, Chen Y, Li X, Huang Y, Chen H, Bao J. The associations of accommodation and aberrations in myopia control with orthokeratology. Ophthalmic Physiol Opt. 2022;42(2):327–34.PubMedCrossRef Ding C, Chen Y, Li X, Huang Y, Chen H, Bao J. The associations of accommodation and aberrations in myopia control with orthokeratology. Ophthalmic Physiol Opt. 2022;42(2):327–34.PubMedCrossRef
56.
Zurück zum Zitat Jakobsen TM, Moller F. Control of myopia using orthokeratology lenses in scandinavian children aged 6 to 12 years. Eighteen-month data from the Danish Randomized Study: clinical study of Near-sightedness; TReatment with orthokeratology lenses (CONTROL study). Acta Ophthalmol. 2022;100(2):175–82.PubMedCrossRef Jakobsen TM, Moller F. Control of myopia using orthokeratology lenses in scandinavian children aged 6 to 12 years. Eighteen-month data from the Danish Randomized Study: clinical study of Near-sightedness; TReatment with orthokeratology lenses (CONTROL study). Acta Ophthalmol. 2022;100(2):175–82.PubMedCrossRef
Metadaten
Titel
Orthokeratology in controlling myopia of children: a meta-analysis of randomized controlled trials
verfasst von
Xue Li
Meiling Xu
Shanshan San
Lanzheng Bian
Hui Li
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Ophthalmology / Ausgabe 1/2023
Elektronische ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-023-03175-x

Weitere Artikel der Ausgabe 1/2023

BMC Ophthalmology 1/2023 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.